Medimix Hematology
  • Home
  • Live from the congress
    • 2025
      • EHA 2025
      • ICML 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
EHA 2024

Multidisciplinary approach to myeloproliferative neoplasms (MPN)

June 25, 2024

Presented by Prof Timothy Devos (UZ Leuven, Belgium)

Prof Timothy Devos, a haematologist at UZ Leuven, chaired a session on myeloproliferative neoplasms (MPN) organised by the specialised working group of the EHA. He provided a comprehensive summary of the presentations delivered by four distinguished speakers.

The first speaker, Prof Passamonti from Milan, Italy, introduced the topic. He elucidated the objectives and key elements of multidisciplinary meetings in the context of MPNs, emphasising the necessity of involving experts from various disciplines. Such collaboration is essential for accurate diagnosis, informed treatment decision-making, and coordinated follow-up strategies.

Dr Lyon, a cardio-oncologist from London, UK, presented on the critical vascular risk factors affecting patients with MPNs and offered guidance on reducing cardiovascular events in these patients. He concluded his presentation by referencing the 2022 ESC guidelines on cardio-oncology, which were developed in collaboration with the EHA.

Prof Kiladjian from Paris, France, concentrated on the management of splanchnic vein thrombosis in JAK2-positive MPN patients. He emphasized the necessity of collaboration with hepatologists for effective management of these patients. At his hospital, a risk score has been developed for MPN patients to assess their risk for splanchnic vein thrombosis, as well as secondary myelofibrosis, acute leukaemia and mortality.

Prof Sobas from Wroclaw, Poland, presented her research on young MPN patients, a group often underrepresented in clinical trials. She highlighted the importance of collaborating with gynaecologists and obstetricians to manage pregnancies in these patients.

Prof Devos concluded his summary by emphasizing that young MPN patients are a key focus of the scientific working group. He underscored the importance of enrolling these patients in registries to collect data on an international scale, given their rarity. This approach aims to generate more conclusive and comprehensive data

References:

Devos T et al.EHA2024 #s266

With the educational support of:

Back to congress overview

Tags:

in-depth

Share Article

Medimix Hematology

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Live from the congress
    • 2025
      • EHA 2025
      • ICML 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
    • Logout
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok